# 68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy

> **NCT06716788** · — · NOT_YET_RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 50 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** 68Ga-HSA

## Key facts

- **NCT ID:** NCT06716788
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06716788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06716788, "68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06716788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*